FDA inspection
SPI Pharma, Inc.: FDA inspection ending Jan 2, 2003
FDA inspection 253185 · Voluntary Action Indicated (VAI) · Grand Haven, MI
Key facts
| Inspection ID | 253185 |
|---|---|
| Firm | SPI Pharma, Inc. |
| FEI number | 1833292 |
| Address | 1711 Tiles Ct |
| City | Grand Haven |
| State | MI |
| ZIP | 49417-2832 |
| Fiscal year | 2003 |
| Inspection end date | Jan 2, 2003 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data